This report contains market size and forecasts of Encephalitis Vaccine in global, including the following market information:
Global Encephalitis Vaccine Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Encephalitis Vaccine Market Sales, 2016-2021, 2022-2027, (M Doses)
Global top five Encephalitis Vaccine companies in 2020 (%)
The global Encephalitis Vaccine market was valued at 1186.3 million in 2020 and is projected to reach US$ 1461.8 million by 2027, at a CAGR of 5.4% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Encephalitis Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Encephalitis Vaccine Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Encephalitis Vaccine Market Segment Percentages, By Type, 2020 (%)
Inactivated Vaccine
Live Attenuated Vaccine
Global Encephalitis Vaccine Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Encephalitis Vaccine Market Segment Percentages, By Application, 2020 (%)
Child
Adult
Global Encephalitis Vaccine Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (M Doses)
Global Encephalitis Vaccine Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Encephalitis Vaccine revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Encephalitis Vaccine revenues share in global market, 2020 (%)
Key companies Encephalitis Vaccine sales in global market, 2016-2021 (Estimated), (M Doses)
Key companies Encephalitis Vaccine sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Valneva
Sanofi Pasteur
Biken
Wuhan Institute of Biological Products
Lanzhou Institute of Biological Products
Chengdu Institute of Biological Products
Tiantan Biological Products
Liaoning Chengda
Zhejiang Tianyuan Bio-Pharmaceutical
Yisheng Bio
Changchun Institute of Biological Products
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Encephalitis Vaccine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Encephalitis Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Encephalitis Vaccine Overall Market Size
2.1 Global Encephalitis Vaccine Market Size: 2021 VS 2027
2.2 Global Encephalitis Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Encephalitis Vaccine Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Encephalitis Vaccine Players in Global Market
3.2 Top Global Encephalitis Vaccine Companies Ranked by Revenue
3.3 Global Encephalitis Vaccine Revenue by Companies
3.4 Global Encephalitis Vaccine Sales by Companies
3.5 Global Encephalitis Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Encephalitis Vaccine Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Encephalitis Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Encephalitis Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Encephalitis Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Encephalitis Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Encephalitis Vaccine Market Size Markets, 2021 & 2027
4.1.2 Inactivated Vaccine
4.1.3 Live Attenuated Vaccine
4.2 By Type - Global Encephalitis Vaccine Revenue & Forecasts
4.2.1 By Type - Global Encephalitis Vaccine Revenue, 2016-2021
4.2.2 By Type - Global Encephalitis Vaccine Revenue, 2022-2027
4.2.3 By Type - Global Encephalitis Vaccine Revenue Market Share, 2016-2027
4.3 By Type - Global Encephalitis Vaccine Sales & Forecasts
4.3.1 By Type - Global Encephalitis Vaccine Sales, 2016-2021
4.3.2 By Type - Global Encephalitis Vaccine Sales, 2022-2027
4.3.3 By Type - Global Encephalitis Vaccine Sales Market Share, 2016-2027
4.4 By Type - Global Encephalitis Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Encephalitis Vaccine Market Size, 2021 & 2027
5.1.2 Child
5.1.3 Adult
5.2 By Application - Global Encephalitis Vaccine Revenue & Forecasts
5.2.1 By Application - Global Encephalitis Vaccine Revenue, 2016-2021
5.2.2 By Application - Global Encephalitis Vaccine Revenue, 2022-2027
5.2.3 By Application - Global Encephalitis Vaccine Revenue Market Share, 2016-2027
5.3 By Application - Global Encephalitis Vaccine Sales & Forecasts
5.3.1 By Application - Global Encephalitis Vaccine Sales, 2016-2021
5.3.2 By Application - Global Encephalitis Vaccine Sales, 2022-2027
5.3.3 By Application - Global Encephalitis Vaccine Sales Market Share, 2016-2027
5.4 By Application - Global Encephalitis Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Encephalitis Vaccine Market Size, 2021 & 2027
6.2 By Region - Global Encephalitis Vaccine Revenue & Forecasts
6.2.1 By Region - Global Encephalitis Vaccine Revenue, 2016-2021
6.2.2 By Region - Global Encephalitis Vaccine Revenue, 2022-2027
6.2.3 By Region - Global Encephalitis Vaccine Revenue Market Share, 2016-2027
6.3 By Region - Global Encephalitis Vaccine Sales & Forecasts
6.3.1 By Region - Global Encephalitis Vaccine Sales, 2016-2021
6.3.2 By Region - Global Encephalitis Vaccine Sales, 2022-2027
6.3.3 By Region - Global Encephalitis Vaccine Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Encephalitis Vaccine Revenue, 2016-2027
6.4.2 By Country - North America Encephalitis Vaccine Sales, 2016-2027
6.4.3 US Encephalitis Vaccine Market Size, 2016-2027
6.4.4 Canada Encephalitis Vaccine Market Size, 2016-2027
6.4.5 Mexico Encephalitis Vaccine Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Encephalitis Vaccine Revenue, 2016-2027
6.5.2 By Country - Europe Encephalitis Vaccine Sales, 2016-2027
6.5.3 Germany Encephalitis Vaccine Market Size, 2016-2027
6.5.4 France Encephalitis Vaccine Market Size, 2016-2027
6.5.5 U.K. Encephalitis Vaccine Market Size, 2016-2027
6.5.6 Italy Encephalitis Vaccine Market Size, 2016-2027
6.5.7 Russia Encephalitis Vaccine Market Size, 2016-2027
6.5.8 Nordic Countries Encephalitis Vaccine Market Size, 2016-2027
6.5.9 Benelux Encephalitis Vaccine Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Encephalitis Vaccine Revenue, 2016-2027
6.6.2 By Region - Asia Encephalitis Vaccine Sales, 2016-2027
6.6.3 China Encephalitis Vaccine Market Size, 2016-2027
6.6.4 Japan Encephalitis Vaccine Market Size, 2016-2027
6.6.5 South Korea Encephalitis Vaccine Market Size, 2016-2027
6.6.6 Southeast Asia Encephalitis Vaccine Market Size, 2016-2027
6.6.7 India Encephalitis Vaccine Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Encephalitis Vaccine Revenue, 2016-2027
6.7.2 By Country - South America Encephalitis Vaccine Sales, 2016-2027
6.7.3 Brazil Encephalitis Vaccine Market Size, 2016-2027
6.7.4 Argentina Encephalitis Vaccine Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Encephalitis Vaccine Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Encephalitis Vaccine Sales, 2016-2027
6.8.3 Turkey Encephalitis Vaccine Market Size, 2016-2027
6.8.4 Israel Encephalitis Vaccine Market Size, 2016-2027
6.8.5 Saudi Arabia Encephalitis Vaccine Market Size, 2016-2027
6.8.6 UAE Encephalitis Vaccine Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Valneva
7.1.1 Valneva Corporate Summary
7.1.2 Valneva Business Overview
7.1.3 Valneva Encephalitis Vaccine Major Product Offerings
7.1.4 Valneva Encephalitis Vaccine Sales and Revenue in Global (2016-2021)
7.1.5 Valneva Key News
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Corporate Summary
7.2.2 Sanofi Pasteur Business Overview
7.2.3 Sanofi Pasteur Encephalitis Vaccine Major Product Offerings
7.2.4 Sanofi Pasteur Encephalitis Vaccine Sales and Revenue in Global (2016-2021)
7.2.5 Sanofi Pasteur Key News
7.3 Biken
7.3.1 Biken Corporate Summary
7.3.2 Biken Business Overview
7.3.3 Biken Encephalitis Vaccine Major Product Offerings
7.3.4 Biken Encephalitis Vaccine Sales and Revenue in Global (2016-2021)
7.3.5 Biken Key News
7.4 Wuhan Institute of Biological Products
7.4.1 Wuhan Institute of Biological Products Corporate Summary
7.4.2 Wuhan Institute of Biological Products Business Overview
7.4.3 Wuhan Institute of Biological Products Encephalitis Vaccine Major Product Offerings
7.4.4 Wuhan Institute of Biological Products Encephalitis Vaccine Sales and Revenue in Global (2016-2021)
7.4.5 Wuhan Institute of Biological Products Key News
7.5 Lanzhou Institute of Biological Products
7.5.1 Lanzhou Institute of Biological Products Corporate Summary
7.5.2 Lanzhou Institute of Biological Products Business Overview
7.5.3 Lanzhou Institute of Biological Products Encephalitis Vaccine Major Product Offerings
7.5.4 Lanzhou Institute of Biological Products Encephalitis Vaccine Sales and Revenue in Global (2016-2021)
7.5.5 Lanzhou Institute of Biological Products Key News
7.6 Chengdu Institute of Biological Products
7.6.1 Chengdu Institute of Biological Products Corporate Summary
7.6.2 Chengdu Institute of Biological Products Business Overview
7.6.3 Chengdu Institute of Biological Products Encephalitis Vaccine Major Product Offerings
7.6.4 Chengdu Institute of Biological Products Encephalitis Vaccine Sales and Revenue in Global (2016-2021)
7.6.5 Chengdu Institute of Biological Products Key News
7.7 Tiantan Biological Products
7.7.1 Tiantan Biological Products Corporate Summary
7.7.2 Tiantan Biological Products Business Overview
7.7.3 Tiantan Biological Products Encephalitis Vaccine Major Product Offerings
7.4.4 Tiantan Biological Products Encephalitis Vaccine Sales and Revenue in Global (2016-2021)
7.7.5 Tiantan Biological Products Key News
7.8 Liaoning Chengda
7.8.1 Liaoning Chengda Corporate Summary
7.8.2 Liaoning Chengda Business Overview
7.8.3 Liaoning Chengda Encephalitis Vaccine Major Product Offerings
7.8.4 Liaoning Chengda Encephalitis Vaccine Sales and Revenue in Global (2016-2021)
7.8.5 Liaoning Chengda Key News
7.9 Zhejiang Tianyuan Bio-Pharmaceutical
7.9.1 Zhejiang Tianyuan Bio-Pharmaceutical Corporate Summary
7.9.2 Zhejiang Tianyuan Bio-Pharmaceutical Business Overview
7.9.3 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Major Product Offerings
7.9.4 Zhejiang Tianyuan Bio-Pharmaceutical Encephalitis Vaccine Sales and Revenue in Global (2016-2021)
7.9.5 Zhejiang Tianyuan Bio-Pharmaceutical Key News
7.10 Yisheng Bio
7.10.1 Yisheng Bio Corporate Summary
7.10.2 Yisheng Bio Business Overview
7.10.3 Yisheng Bio Encephalitis Vaccine Major Product Offerings
7.10.4 Yisheng Bio Encephalitis Vaccine Sales and Revenue in Global (2016-2021)
7.10.5 Yisheng Bio Key News
7.11 Changchun Institute of Biological Products
7.11.1 Changchun Institute of Biological Products Corporate Summary
7.11.2 Changchun Institute of Biological Products Encephalitis Vaccine Business Overview
7.11.3 Changchun Institute of Biological Products Encephalitis Vaccine Major Product Offerings
7.11.4 Changchun Institute of Biological Products Encephalitis Vaccine Sales and Revenue in Global (2016-2021)
7.11.5 Changchun Institute of Biological Products Key News
8 Global Encephalitis Vaccine Production Capacity, Analysis
8.1 Global Encephalitis Vaccine Production Capacity, 2016-2027
8.2 Encephalitis Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Encephalitis Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Encephalitis Vaccine Supply Chain Analysis
10.1 Encephalitis Vaccine Industry Value Chain
10.2 Encephalitis Vaccine Upstream Market
10.3 Encephalitis Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Encephalitis Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
List of Tables
Table 1. Key Players of Encephalitis Vaccine in Global Market
Table 2. Top Encephalitis Vaccine Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Encephalitis Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Encephalitis Vaccine Revenue Share by Companies, 2016-2021
Table 5. Global Encephalitis Vaccine Sales by Companies, (M Doses), 2016-2021
Table 6. Global Encephalitis Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Encephalitis Vaccine Price (2016-2021) & (USD/Dose)
Table 8. Global Manufacturers Encephalitis Vaccine Product Type
Table 9. List of Global Tier 1 Encephalitis Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Encephalitis Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type